Duchenne Muscular Dystrophy Treatment Market Estimated to Witness...

a adăugat un fișier Alte

2024-09-26 13:47:11 -

Duchenne Muscular Dystrophy Treatment Market Estimated to Witness High Growth

The global Duchenne muscular dystrophy treatment market is estimated to be valued at US$ 2 billion in 2024 and is expected to exhibit a CAGR of 47% over the forecast period 2024-2028.Key TakeawaysKey players operating in the Duchenne muscular dystrophy treatment are Sarepta Therapeutics, Pfizer, PTC Therapeutics, Summit Therapeutics, and others. Sarepta Therapeutics' Exondys 51 was the first...

0 Commentarii 0 Distribuiri 277 Views 0 previzualizare